wellrank.ai
Sequel logo

Sequel

First cited by AI Jun 13, 2026
sequelhealth.com

Surfaced organically in AI answers about wegovy. Not yet profiled.

AI Visibility

Visibility trend

Wegovy, daily share of AI answers mentioning Sequel, through Jun 13, 2026.

8.3%

Avg position when mentioned: 3.0

By engine

Where Sequel is strong, and where it is invisible.

  • Google AI
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 1 positive mentions
  • 0 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Sequel

Google AIJun 13, 2026, 11:10 UTC
What are the best online weight loss programs that include Wegovy?

When considering online weight loss programs that include Wegovy (semaglutide), it's important to understand that Wegovy is a prescription medication. This means that any legitimate online program will require a consultation with a healthcare provider, who will then prescribe Wegovy if it's deemed appropriate for you. Here are some of the best online weight loss programs that can facilitate access to Wegovy, along with why they are good choices: Hims & Hers: Why: Hims & Hers offers a comprehensive telehealth platform that includes access to licensed healthcare providers who can assess your eligibility for weight loss medications like Wegovy. They have a dedicated weight loss program that focuses on a holistic approach, combining medication with lifestyle coaching and support. They are known for their streamlined online process, from initial consultation to prescription delivery. Rory: Why: Rory is another excellent telehealth provider that focuses on women's health but also offers weight loss solutions for everyone. They connect you with a doctor who can evaluate your needs and prescribe medications like Wegovy. Their programs often include personalized treatment plans and ongoing support from healthcare professionals. Sequel (formerly Kickstart Health): Why: Sequel is specifically designed for comprehensive weight management, and they are known for offering access to GLP-1 medications like Wegovy. They emphasize a science-backed approach, combining medication with nutrition, exercise, and behavioral coaching. Their platform often includes regular check-ins with a care team. Calibrate: Why: Calibrate is a popular program that focuses on metabolic health and offers a personalized approach to weight loss, often including GLP-1 medications. They pair you with a doctor and a health coach and provide a structured curriculum designed to help you build sustainable habits alongside medication. They require a commitment to their year-long program. PlushCare: Why: PlushCare offers on-demand telehealth appointments with board-certified doctors. They have a weight management service where you can discuss your goals and potentially get a prescription for medications like Wegovy if your doctor determines it's a suitable option for you. They are known for their ease of access and quick appointment scheduling. Important Considerations When Choosing a Program: Prescription Requirement: Remember that Wegovy is a powerful medication. These programs will not* simply sell you Wegovy without a thorough medical evaluation. You will need to consult with a healthcare provider to determine if it's safe and appropriate for you. Holistic Approach: The best programs go beyond just the medication. Look for those that offer nutrition guidance, exercise support, behavioral coaching, and ongoing monitoring to ensure long-term success. Cost: Wegovy can be expensive, and insurance coverage varies. Be sure to understand the program costs, medication costs, and potential insurance reimbursement options before committing. Medical Supervision: Ensure the program prioritizes your health and safety by having qualified medical professionals oversee your treatment plan. Eligibility Criteria: Wegovy is typically prescribed for individuals with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition. Programs will have their own specific eligibility criteria. Always do your own research and consult with your primary care physician if you have any underlying health concerns before starting any new weight loss program or medication.

Mentioned in position 3 of 5

Read full answer with sources →

Public AI visibility history

Daily rank of Sequel on our buyer intent questions, per category. A dash means the engines did not cite Sequel at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Wegovy#29

TL;DR

Sequel is a telehealth platform focused on weight management and GLP-1 medication access, including Wegovy. The company connects patients with licensed clinicians who can prescribe and manage obesity treatments. In WellRank's latest index, Sequel ranks 13th in AI-generated answers about Wegovy with 8% visibility, and the single mention captured in the corpus carries a positive tone.

Company Overview

Sequel operates as a direct-to-patient telehealth service built around medically supervised weight loss, with a business model centered on connecting individuals to clinicians for prescription management and ongoing care. Its founding details and headquarters are not publicly disclosed in widely available sources. The platform appears to position itself as a clinical-first alternative to broader consumer wellness apps.

Product Features

  • Telehealth consultations with licensed clinicians for weight management
  • Access to GLP-1 medications such as Wegovy through prescription
  • Ongoing medication management and follow-up care
  • Personalized obesity treatment planning
  • Digital platform for patient-provider communication

Target Market

Sequel primarily serves adults seeking medically supervised weight loss, particularly those interested in GLP-1 receptor agonist therapies. Its geographic availability is not publicly confirmed in detail, though it operates within the US telehealth regulatory framework. The platform targets individuals who prefer a clinical, physician-led approach over general wellness coaching.

Buyer Personas

  • A middle-aged adult with obesity who has struggled with diet and exercise alone and is researching prescription weight-loss medications like Wegovy.
  • A busy professional who wants convenient online access to a clinician rather than visiting a physical weight-loss clinic.
  • Someone recently diagnosed with weight-related health conditions who is looking for structured, medically supervised intervention.
  • A patient already aware of GLP-1 treatments who is comparing telehealth providers before committing to a program.

Funding & Performance

Funding stage, total capital raised, and valuation are not publicly disclosed. The company does not appear to be publicly traded.

Recent Developments

Sequel has gained enough organic presence to surface in AI-generated answers related to Wegovy, suggesting growing awareness in the GLP-1 telehealth category. Specific product launches or partnership announcements are not widely documented in publicly available sources at this time.

Competitive Landscape

According to WellRank co-mention data, AI engines most frequently cite Sequel alongside Rory, PlushCare, Hims & Hers, and Calibrate when answering questions about Wegovy. This places Sequel in a competitive tier of telehealth providers racing to capture GLP-1 prescribing market share. At 8% AI visibility and a 13th-place ranking, it trails better-established brands in this space but has achieved meaningful organic surfacing.

Sequel vs the brands AI recommends alongside it

The real competitive set in Wegovy: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Sequel logo
SequelThis brand
#29
8.3%
Calibrate logo
Calibrate

1 shared answers

#3
50.0%
Hims & Hers logo
Hims & Hers

1 shared answers

#1
66.7%
PlushCare logo
PlushCare

1 shared answers

#4
41.7%
Rory logo
Rory

1 shared answers

#28
8.3%

Email me when overtakes Sequel

One email the day the ranks flip. Nothing else.

User Sentiment

Within WellRank's current corpus, Sequel's sole captured AI mention carries a positive tone, with no neutral or cautious mentions recorded. Because the sample is limited to one mention, this sentiment reading should be treated as directional rather than definitive. Broader public review data is not prominently available through widely known sources, making a fuller sentiment picture difficult to establish at this stage.

Pricing

Pricing for Sequel's consultations and medication programs is not published in widely available sources. As is common in GLP-1 telehealth, costs likely vary based on the prescribed medication, insurance coverage, and program structure.

Sources cited around Sequel

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Sequel weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Sequel? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.